We further demonstrate that this differentiation process toward the CD24- phenotype in the CD24+/IGF1R-KD is significantly enhanced as a result of the tumor microenvironment; the distribution of CD24- and CD24+ subsets was not affected in vitro as a result of the IGF1R-KD (Additional file 4: Figure S4). The gene discussed is CD24; the disease is neoplasm.